Challenges and Perspectives in the Treatment of Diabetes Associated Breast Cancer

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015

Fitzmaurice, C., Allen, C., Barber, R. M., Barregård, L., Bhutta, Z. A., Brenner, H., Dicker, D., Chimed‐Ochir, O., Dandona, R., Dandona, L., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.5688 · Cited by 6,229 · see citing works

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

Lehmann, B. D., Bauer, J. A., Chen, X., Sanders, M. E., Chakravarthy, A. B., Shyr, Y., & Pietenpol, J. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45014 · Cited by 5,592 · see citing works

Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases

MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583 · see citing works

Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016

Naghavi, M., Abajobir, A. A., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abera, S. F., Aboyans, V., Adetokunboh, O., Afshin, A., Agrawal, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32152-9 · Cited by 4,821 · see citing works

HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia

Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905 · see citing works

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

Goldhirsch, A., Wood, W. C., Coates, A. S., Gelber, R. D., Thurlimann, B. J. K., & Senn, H.-J. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr304 · Cited by 3,839 · see citing works

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

Bianchini, G., Balko, J. M., Mayer, I. A., Sanders, M. E., & Gianni, L. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.66 · Cited by 3,079 · see citing works

Metformin and reduced risk of cancer in diabetic patients

Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388 · see citing works

Mechanisms for Insulin Resistance: Common Threads and Missing Links

Samuel, V. T., & Shulman, G. I. (2012) · Cell · doi:10.1016/j.cell.2012.02.017 · Cited by 2,294 · see citing works

Cellular Fatty Acid Metabolism and Cancer

Currie, E., Schulze, A., Zechner, R., Walther, T. C., & Farese, R. V. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.05.017 · Cited by 2,123 · see citing works

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

Sotiriou, C. P., Neo, S.-Y., McShane, L. M., Korn, E. L., Long, P. M., Jazaeri, A. A., Martiat, P., Fox, S. B., Harris, A. L., & Liu, E. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1732912100 · Cited by 1,993 · see citing works

Globalization of Diabetes

Hu, F. B. (2011) · Diabetes Care · doi:10.2337/dc11-0442 · Cited by 1,954 · see citing works

The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress

Shaw, R. J., Kosmatka, M., Bardeesy, N., Hurley, R. L., Witters, L. A., DePinho, R. A., & Cantley, L. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308061100 · Cited by 1,797 · see citing works

A Mitochondria-K+ Channel Axis Is Suppressed in Cancer and Its Normalization Promotes Apoptosis and Inhibits Cancer Growth

Bonnet, S., Archer, S. L., Allalunis‐Turner, J., Haromy, A., Beaulieu, C., Thompson, R. B., Lee, C. T., Lopaschuk, G. D., Puttagunta, L., Bonnet, S. B., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.10.020 · Cited by 1,530 · see citing works

Metformin: An Old Drug for the Treatment of Diabetes But a New Drug for the Protection of the Endothelium

Kinaan, M., Ding, H., & Triggle, C. R. (2015) · Medical Principles and Practice · doi:10.1159/000381643 · Cited by 1,515 · see citing works

Lipid metabolism in cancer

Santos, C. R., & Schulze, A. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08644.x · Cited by 1,344 · see citing works

Cancer metabolism: fatty acid oxidation in the limelight

Carracedo, A., Cantley, L. C., & Pandolfi, P. P. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3483 · Cited by 1,316 · see citing works

MECHANISMS OF ENDOCRINE RESISTANCE IN BREAST CANCER

Osborne, C., & Schiff, R. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-070909-182917 · Cited by 1,205 · see citing works

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

Currie, C. J., Poole, C. D., & Gale, E. A. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1440-6 · Cited by 1,124 · see citing works

Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping

Dai, X., Cheng, H., Bai, Z., & Li, J. (2017) · Journal of Cancer · doi:10.7150/jca.18457 · Cited by 1,106 · see citing works

Mechanism by which metformin reduces glucose production in type 2 diabetes.

Hundal, R. S., Krssak, M., Dufour, S., Laurent, D., Lebon, V, Chandramouli, V, Inzucchi, S. E., Schumann, W. C., Petersen, K. F., Landau, B. R., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2063 · Cited by 1,052 · see citing works

Diabetes and cancer

Vigneri, P., Frasca, F., Sciacca, L., Pandini, G., & Vigneri, R. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0087 · Cited by 1,009 · see citing works

Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action

Shu, Y., Sheardown, S. A., Brown, C., Owen, R., Zhang, S., Castro, R. A., Ianculescu, A. G., Lin, Y., Lo, J. C.-M., Burchard, E. G., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30558 · Cited by 971 · see citing works

Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer

Jiralerspong, S., Palla, S. L., Giordano, S. H., Meric-Bernstam, F., Liedtke, C., Barnett, C. M., Hsu, L., Hung, M.-C., Hortobagyi, G. N., & Gonzalez-Angulo, A. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.19.6410 · Cited by 880 · see citing works

Diabetes mellitus and risk of breast cancer: A meta‐analysis

Larsson, S. C., Mantzoros, C. S., & Wolk, A. (2007) · International Journal of Cancer · doi:10.1002/ijc.22717 · Cited by 875 · see citing works

The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level

Sahra, I. B., Laurent, K., Loubat, A., Giorgetti-Peraldi, S., Colosetti, P., Auberger, P., Tanti, J. F., Le Marchand-Brustel, Y., & Bost, F. (2008) · Oncogene · doi:10.1038/sj.onc.1211024 · Cited by 861 · see citing works

Loss of FBP1 by Snail-Mediated Repression Provides Metabolic Advantages in Basal-like Breast Cancer

Dong, C., Yuan, T., Wu, Y., Wang, Y., Fan, T. W. ‐., Miriyala, S., Lin, Y., Yao, J., Shi, J., Kang, T., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.01.022 · Cited by 806 · see citing works

27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology

Nelson, E. R., Wardell, S., Jasper, J. S., Park, S., Suchindran, S., Howe, M. K., Carver, N. J., Pillai, R. V., Sullivan, P., Sondhi, V., et al. (2013) · Science · doi:10.1126/science.1241908 · Cited by 805 · see citing works

Triple-Negative Breast Cancer: An Unmet Medical Need

Hudis, C. A., & Gianni, L. (2011) · The Oncologist · doi:10.1634/theoncologist.2011-s1-01 · Cited by 783 · see citing works

Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies

Ben, Q., Xu, M., Ning, X., Liu, J., Hong, S., Huang, W., Zhang, H., & Li, Z. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.03.003 · Cited by 685 · see citing works

Emerging roles of lipid metabolism in cancer metastasis

Luo, X., Cheng, C., Tan, Z., Li, N., Tang, M., Yang, L., & Cao, Y. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0646-3 · Cited by 681 · see citing works

Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer

Michelakis, E. D., Webster, L., & Mackey, J. R. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604554 · Cited by 657 · see citing works

The Role of Adiponectin in Cancer: A Review of Current Evidence

Dalamaga, Μ., Diakopoulos, K. N., & Mantzoros, C. S. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1015 · Cited by 639 · see citing works

Biology, Metastatic Patterns, and Treatment of Patients with Triple-Negative Breast Cancer

Anders, C. K., & Carey, L. (2009) · Clinical Breast Cancer · doi:10.3816/cbc.2009.s.008 · Cited by 625 · see citing works

Metformin: An Old But Still the Best Treatment for Type 2 Diabetes

Rojas, L. B. A., & Gomes, M. B. (2013) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-5-6 · Cited by 567 · see citing works

Diabetic Cardiomyopathy

Poornima, I. G., Parikh, P., & Shannon, R. P. (2006) · Circulation Research · doi:10.1161/01.res.0000207406.94146.c2 · Cited by 567 · see citing works

Hyperglycemia Induces a Dynamic Cooperativity of Histone Methylase and Demethylase Enzymes Associated With Gene-Activating Epigenetic Marks That Coexist on the Lysine Tail

Brasacchio, D., Okabe, J., Tikellis, C., Balcerczyk, A., George, P., Baker, E. K., Calkin, A. C., Brownlee, M., Cooper, M. E., & El‐Osta, A. (2009) · Diabetes · doi:10.2337/db08-1666 · Cited by 533 · see citing works

Cancer biomarker discovery and validation.

Goossens, N., Nakagawa, S., Sun, X., & Hoshida, Y. (2015) · PubMed · doi:10.3978/j.issn.2218-676x.2015.06.04 · Cited by 520 · see citing works

Partial and transient reduction of glycolysis by PFKFB3 blockade reduces pathological angiogenesis.

Schoors, S., de Bock, K., Cantelmo, A., Georgiadou, M., Ghesquière, B., Cauwenberghs, S., Kuchnio, A., Wong, B. W., Quaegebeur, A., Goveia, J., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.11.008 · Cited by 512 · see citing works

GSK-3 as potential target for therapeutic intervention in cancer

McCubrey, J. A., Steelman, L. S., Bertrand, F. E., Davis, N. M., Sokolosky, M. L., Abrams, S. L., Montalto, G., D’Assoro, A. B., Libra, M., Nicoletti, F., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2037 · Cited by 509 · see citing works

Multiple Signaling Pathways of the Insulin-Like Growth Factor 1 Receptor in Protection from Apoptosis

Peruzzi, F., di Prisco, M., Dews, M., Salomoni, P., Grassilli, E., Romano, G., Calabretta, B., & Baserga, R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.7203 · Cited by 497 · see citing works

Platelet activation in type 2 diabetes mellitus

Ferroni, P., Basili, S., Falco, A., & Davì, G. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00836.x · Cited by 493 · see citing works

Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stressPreprint

Zaugg, K., Yao, Y., Reilly, P. T., Kannan, K., Kiarash, R., Mason, J. M., Huang, P., Sawyer, S. K., Fuerth, B. J., Faubert, B., et al. (2011) · Genes & Development · doi:10.1101/gad.1987211 · Cited by 493 · see citing works

GSK-3: Functional Insights from Cell Biology and Animal Models

Kaidanovich‐Beilin, O., & Woodgett, J. R. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00040 · Cited by 490 · see citing works

Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes

Rakha, E. A., Elsheikh, S. E., Aleskandarany, M. A., Habashi, H. O., Green, A. R., Powe, D. G., El‐Sayed, M. E., Benhasouna, A., Brunet, J., Akslen, L. A., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2132 · Cited by 490 · see citing works

Effect of Genetic Variation in the Organic Cation Transporter 1, OCT1, on Metformin Pharmacokinetics

Shu, Y., Brown, C., Castro, R. A., Shi, R., Lin, E., Owen, R., Sheardown, S., Yue, L., Burchard, E. G., Brett, C., et al. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100275 · Cited by 474 · see citing works

Crosstalk between Estrogen Receptor and Growth Factor Receptor Pathways as a Cause for Endocrine Therapy Resistance in Breast Cancer

Osborne, C. K., Shou, J., Massarweh, S. A., & Schiff, R. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.865s.11.2 · Cited by 459 · see citing works

Aldose Reductase, Oxidative Stress, and Diabetic Mellitus

Tang, W. H., Martin, K. A., & Hwa, J. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00087 · Cited by 458 · see citing works

Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis

Coyle, C., Cafferty, F. H., Vale, C. L., & Langley, R. E. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw410 · Cited by 453 · see citing works

Diabetes Mellitus and Breast Cancer Outcomes: A Systematic Review and Meta-Analysis

Peairs, K. S., Barone, B. B., Snyder, C. F., Yeh, H., Stein, K. B., Derr, R. L., Brancati, F. L., & Wolff, A. C. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.3011 · Cited by 451 · see citing works

Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: A systematic review and meta‐analysis of cohort studies

Wang, C., Wang, X., Gong, G., Ben, Q., Qiu, W., Chen, Y., Guo-ping, L., & Wang, L. (2011) · International Journal of Cancer · doi:10.1002/ijc.26165 · Cited by 450 · see citing works

The Warburg Effect and the Hallmarks of Cancer

Schwartz, L. H., Supuran, C. T., & Alfarouk, K. O. (2017) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520616666161031143301 · Cited by 427 · see citing works

Diabetes mellitus and breast cancer

Wolf, I., Sadetzki, S., Catane, R., Karasik, A., & Kaufman, B. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)01736-5 · Cited by 422 · see citing works

Glucose metabolism inhibits apoptosis in neurons and cancer cells by redox inactivation of cytochrome c

Vaughn, A. E., & Deshmukh, M. (2008) · Nature Cell Biology · doi:10.1038/ncb1807 · Cited by 408 · see citing works

Triple-negative breast cancer: treatment challenges and solutions

Jérusalem, G., Collignon, J., Schroeder, H., & Lousberg, L. (2016) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s69488 · Cited by 393 · see citing works

Metformin induces unique biological and molecular responses in triple negative breast cancer cells

Liu, B., Fan, Z., Edgerton, S. M., Deng, X.-S., Alimova, I. N., Lind, S. E., & Thor, A. D. (2009) · Cell Cycle · doi:10.4161/cc.8.13.8814 · Cited by 392 · see citing works

Targeting lipid metabolism of cancer cells: A promising therapeutic strategy for cancer

Liu, Q., Luo, Q., Halim, A., & Song, G. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.05.002 · Cited by 381 · see citing works

Adiponectin Inhibits Cell Proliferation by Interacting with Several Growth Factors in an Oligomerization-dependent Manner

Wang, Y., Lam, K. S. L., Xu, J. Y., Lü, G., Xu, L. Y., Cooper, G. J. S., & Xu, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501149200 · Cited by 380 · see citing works

The fate of chemoresistance in triple negative breast cancer (TNBC)

O'Reilly, E. A., Gubbins, L., Sharma, S., Tully, R., Ho, M., Weiner‐Gorzel, K., McCaffrey, J., Harrison, M., Furlong, F. M., Kell, M., et al. (2015) · BBA Clinical · doi:10.1016/j.bbacli.2015.03.003 · Cited by 378 · see citing works

Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer

Saini, K. S., Loi, S., de Azambuja, E., Metzger, O., Saini, M. L., Ignatiadis, M., Dancey, J. E., & Piccart, M. J. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.03.009 · Cited by 376 · see citing works

The biology of cancer testis antigens: Putative function, regulation and therapeutic potential

Fratta, E., Coral, S., Covre, A., Parisi, G., Colizzi, F., Danielli, R., Nicolay, H. J. M., Sigalotti, L., & Maio, M. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2011.02.001 · Cited by 371 · see citing works

Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli

Garofalo, C., Koda, M., Cascio, S., Sulkowska, M., Kanczuga-Koda, L., Golaszewska, J., Russo, A., Sulkowski, S., & Surmacz, E. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1913 · Cited by 370 · see citing works

Diabetes and breast cancer risk: A meta-analysis

Boyle, P., Boniol, M., Koechlin, A., Robertson, C., Valentini, F., Coppens, K., Fairley, L.-L., Boniol, M., Zheng, T., Zhang, Y., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.414 · Cited by 358 · see citing works

Obesity and Cancer: The Oil that Feeds the Flame

Font-Burgada, J., Sun, B., & Karin, M. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.015 · Cited by 354 · see citing works

Prospective Study of Hyperglycemia and Cancer Risk

Stattin, P. E., Björ, O., Ferrari, P., Lukanova, A., Lenner, P., Lindahl, B., Hallmans, G., & Kaaks, R. (2007) · Diabetes Care · doi:10.2337/dc06-0922 · Cited by 352 · see citing works

Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells

Dieudonné, M., Bussière, M., Santos, E. D., Leneveu, M.-C., Giudicelli, Y., & Pecquery, R. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.04.076 · Cited by 347 · see citing works

Elevated insulin receptor content in human breast cancer

Papa, V, Pezzino, V, Costantino, A., Belfiore, A., Giuffrida, D., Frittitta, L., Vannelli, G. B., Brand, R., Goldfine, I. D., & Vigneri, R. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114868 · Cited by 338 · see citing works

Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance

Denduluri, S. K., Idowu, O. A., Wang, Z., Liao, Z., Yan, Z., Mohammed, M. K., Ye, J., Wei, Q., Wang, J., Zhao, L., et al. (2014) · Genes & Diseases · doi:10.1016/j.gendis.2014.10.004 · Cited by 333 · see citing works

Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma.

Milgraum, L. Z., Witters, L. A., Pasternack, G. R., & Kuhajda, F. P. (1997) · PubMed · Cited by 333 · see citing works

Hyperglycemia as a Risk Factor for Cancer Progression

Ryu, T. Y., Park, J., & Scherer, P. E. (2014) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2014.38.5.330 · Cited by 331 · see citing works

Molecular and Cellular Heterogeneity in Breast Cancer

Rivenbark, A. G., O’Connor, S., & Coleman, W. B. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.08.002 · Cited by 327 · see citing works

The Link between the Metabolic Syndrome and Cancer

Braun, S. L., Bitton-Worms, K., & LeRoith, D. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.1003 · Cited by 326 · see citing works

Obesity and diabetes: An update

Verma, S., & Hussain, M. E. (2016) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2016.06.017 · Cited by 322 · see citing works

Oncogenic cancer/testis antigens: prime candidates for immunotherapy

Gjerstorff, M. F., Andersen, M. H., & Ditzel, H. J. (2015) · Oncotarget · doi:10.18632/oncotarget.4694 · Cited by 320 · see citing works

Diabetes and pancreatic cancer

Li, D. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20771 · Cited by 315 · see citing works

Ceramide glycosylation potentiates cellular multidrug resistance

Liu, Y., Han, T.-Y., Giuliano, A. E., & Cabot, M. C. (2001) · The FASEB Journal · doi:10.1096/fj.00-0223com · Cited by 304 · see citing works

27-Hydroxycholesterol Is an Endogenous Selective Estrogen Receptor Modulator

DuSell, C. D., Umetani, M., Shaul, P. W., Mangelsdorf, D. J., & McDonnell, D. P. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0383 · Cited by 298 · see citing works

ROS-Mediated DNA Methylation Pattern Alterations in Carcinogenesis

Wu, Q., & Ni, X. (2015) · Current Drug Targets · doi:10.2174/1389450116666150113121054 · Cited by 292 · see citing works

Metformin Induces Apoptosis and Cell Cycle Arrest Mediated by Oxidative Stress, AMPK and FOXO3a in MCF-7 Breast Cancer Cells

de Queiroz, E. A. I. F., Puukila, S., Eichler, R. A. D. S., Sampaio, S. C., Forsyth, H. L., Lees, S. J., Barbosa, A. M., Dekker, R. F. H., Fortes, Z. B., & Khaper, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098207 · Cited by 281 · see citing works

Metformin in cancer

Mallik, R., & Chowdhury, T. A. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.05.023 · Cited by 266 · see citing works

Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention

Davis, N. M., Sokolosky, M. L., Stadelman, K. M., Abrams, S. L., Libra, M., Candido, S., Nicoletti, F., Polesel, J., Maestro, R., D’Assoro, A. B., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2209 · Cited by 252 · see citing works

Teaching the basics of cancer metabolism: Developing antitumor strategies by exploiting the differences between normal and cancer cell metabolism

Kalyanaraman, B. (2017) · Redox Biology · doi:10.1016/j.redox.2017.04.018 · Cited by 246 · see citing works

Diabetes mellitus and cancer risk: Review of the epidemiological evidence

Shikata, K., Ninomiya, T., & Kiyohara, Y. (2012) · Cancer Science · doi:10.1111/cas.12043 · Cited by 244 · see citing works

Hyperglycemia, a Neglected Factor during Cancer Progression

Duan, W., Shen, X., Lei, J., Xu, Q., Yu, Y., Li, R., Wu, E., & Ma, Q. (2014) · BioMed Research International · doi:10.1155/2014/461917 · Cited by 239 · see citing works

Crosstalk Between the Insulin-Like Growth Factors and Estrogens in Breast Cancer

Yee, D., & Lee, A. V. (2000) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1009575518338 · Cited by 234 · see citing works

PI3K-AKT-mTOR inhibitors in breast cancers: From tumor cell signaling to clinical trials

Dey, N., De, P. K., & Leyland-Jones, B. R. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.037 · Cited by 232 · see citing works

Autophagy

Bhutia, S. K., Mukhopadhyay, S., Sinha, N., Das, D. N., Panda, P. K., Patra, S. K., Maiti, T. K., Mandal, M., Dent, P., Wang, X., et al. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-407173-5.00003-0 · Cited by 230 · see citing works

Up-regulation of Acetyl-CoA Carboxylase α and Fatty Acid Synthase by Human Epidermal Growth Factor Receptor 2 at the Translational Level in Breast Cancer Cells

Yoon, S., Lee, M.-Y., Park, S. W., Moon, J., Koh, Y.-K., Ahn, Y., Park, B., & Kim, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702854200 · Cited by 225 · see citing works

Diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies

Jiang, Y., Ben, Q., Shen, H., Lu, W., Zhang, Y., & Zhu, J. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9617-y · Cited by 220 · see citing works

Fatty acid metabolism in breast cancer subtypes

Monaco, M. E. (2017) · Oncotarget · doi:10.18632/oncotarget.15494 · Cited by 216 · see citing works

Diabetes, Metformin, and Breast Cancer in Postmenopausal Women

Chlebowski, R. T., McTiernan, A., Wactawski‐Wende, J., Manson, J. E., Aragaki, A. K., Rohan, T. E., Ipp, E., Kaklamani, V., Vitolins, M. Z., Wallace, R. B., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.7505 · Cited by 214 · see citing works

Systematic review and meta-analysis of the association between diabetes mellitus and incidence and mortality in breast and colorectal cancer

de Bruijn, K. M. J., Arends, L. R., Hansen, B. E., Leeflang, S., Ruiter, R., & van Eijck, C. H. J. (2013) · British journal of surgery · doi:10.1002/bjs.9229 · Cited by 214 · see citing works

Metformin and cancer: Doses, mechanisms and the dandelion and hormetic phenomena

Martı́n-Castillo, B., Vázquez‐Martín, A., Oliveras‐Ferraros, C., & Menéndez, J. A. (2010) · Cell Cycle · doi:10.4161/cc.9.6.10994 · Cited by 211 · see citing works

Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality

Xu, H., Aldrich, M. C., Chen, Q., Liu, H., Peterson, N. B., Dai, Q., Levy, M. A., Shah, A., Han, X., Ruan, X., et al. (2014) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2014-002649 · Cited by 211 · see citing works

Metformin: A Therapeutic Opportunity in Breast Cancer

Gonzalez-Angulo, A. M., & Meric‐Bernstam, F. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1805 · Cited by 209 · see citing works

Tumor Microenvironment and Metabolic Synergy in Breast Cancers: Critical Importance of Mitochondrial Fuels and Function

Martinez‐Outschoorn, U., Sotgia, F., & Lisanti, M. P. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.03.002 · Cited by 208 · see citing works

Insulin receptor expression and function in human breast cancer cell lines.

Milazzo, G., Giorgino, F., Damante, G., Sung, C., Stampfer, M. R., Vigneri, R., Goldfine, I. D., & Belfiore, A. (1992) · PubMed · Cited by 206 · see citing works

Inflammation, Cancer and Oxidative Lipoxygenase Activity are Intimately Linked

Wisastra, R., & Dekker, F. J. (2014) · Cancers · doi:10.3390/cancers6031500 · Cited by 202 · see citing works

Insulin- and Obesity-Related Variables in Early-Stage Breast Cancer: Correlations and Time Course of Prognostic Associations

Goodwin, P. J., Ennis, M., Pritchard, K. I., Trudeau, M., Koo, J., Taylor, S. K., & Hood, N. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.2723 · Cited by 194 · see citing works

Bidirectional Crosstalk between the Estrogen Receptor and Human Epidermal Growth Factor Receptor 2 Signaling Pathways in Breast Cancer: Molecular Basis and Clinical Implications

Giuliano, M., Trivedi, M. V., & Schiff, R. (2013) · Breast Care · doi:10.1159/000354253 · Cited by 193 · see citing works

Endoplasmic reticulum stress associated responses in cancer

Wang, W., Groenendyk, J., & Michalak, M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.01.012 · Cited by 192 · see citing works

Cholesterol and breast cancer pathophysiology

Nelson, E. R., Chang, C.-Y., & McDonnell, D. P. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.10.001 · Cited by 188 · see citing works

Breast cancer molecular subtypes: from TNBC to QNBC.

Hon, J. D., Singh, B., Şahin, A. A., Du, G., Wang, J., Wang, V. Y., Deng, F., Zhang, D. Y., Monaco, M. E., & Lee, P. (2016) · PubMed Central · Cited by 187 · see citing works

Diabetes mellitus and incidence of kidney cancer: a meta-analysis of cohort studies

Larsson, S. C., & Wolk, A. (2011) · Diabetologia · doi:10.1007/s00125-011-2051-6 · Cited by 182 · see citing works

NF-κB, stem cells and breast cancer: the links get stronger

Shostak, K., & Chariot, A. (2011) · Breast Cancer Research · doi:10.1186/bcr2886 · Cited by 180 · see citing works

Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activities in cultured cancer cells

Weinstein, D., Simon, M., Yehezkel, E., Laron, Z., & Werner, H. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.912 · Cited by 179 · see citing works

Triple-Negative Breast Cancer: Molecular Subtypes and New Targets for Therapy

Lehmann, B. D., Pietenpol, J. A., & Tan, A. R. (2015) · American Society of Clinical Oncology Educational Book · doi:10.14694/edbook_am.2015.35.e31 · Cited by 177 · see citing works

Molecular Mechanisms and Emerging Therapeutic Targets of Triple-Negative Breast Cancer Metastasis

Neophytou, C. M., Boutsikos, P., & Papageorgis, P. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00031 · Cited by 171 · see citing works

Metformin: An anti-diabetic drug to fight cancer

Daugan, M. V., Wojcicki, A. D., d’Hayer, B., & Boudy, V. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.10.006 · Cited by 166 · see citing works

Association between diabetes mellitus and breast cancer risk: a meta-analysis of the literature.

Liao, S., Li, J., Wei, W., Wang, L., Zhang, Y., Li, J., Wang, C., & Sun, S. (2011) · PubMed · Cited by 164 · see citing works

Differential Expression of Lipid Metabolism-Related Proteins in Different Breast Cancer Subtypes

Kim, S., Lee, Y., & Koo, J. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119473 · Cited by 164 · see citing works

Diabetes increases the risk of breast cancer: a meta-analysis

Hardefeldt, P. J., Edirimanne, S., & Eslick, G. D. (2012) · Endocrine Related Cancer · doi:10.1530/erc-12-0242 · Cited by 164 · see citing works

Intracellular Lipid Accumulation in Liver and Muscle and the Insulin Resistance Syndrome

Lara‐Castro, C., & Garvey, W. T. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.09.002 · Cited by 163 · see citing works

Role of adipokines and cytokines in obesity-associated breast cancer: Therapeutic targets

Khan, S. U., Shukla, S., Sinha, S., & Meeran, S. M. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.10.001 · Cited by 162 · see citing works

Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2–Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial

Sonnenblick, A., Agbor‐Tarh, D., Bradbury, I., Cosimo, S. D., Azim, H. A., Fumagalli, D., Sarp, S., Wolff, A. C., Andersson, M., Kroep, J. R., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.7722 · Cited by 160 · see citing works

DNA damage and breast cancer risk

Smith, T. R. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg037 · Cited by 159 · see citing works

Glucosylceramide Synthase Blockade Down-Regulates P-Glycoprotein and Resensitizes Multidrug-Resistant Breast Cancer Cells to Anticancer Drugs

Gouazé‐Andersson, V., Liu, Y., Prickett, C. S., Yu, J. Y., Giuliano, A. E., & Cabot, M. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2329 · Cited by 158 · see citing works

Angiogenesis, adipokines and breast cancer

Vona-Davis, L., & Rose, D. P. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.05.007 · Cited by 148 · see citing works

IGF-II and IGFBP-2 differentially regulate PTEN in human breast cancer cells

Perks, C. M., Vernon, E. G., Rosendahl, A. H., Tonge, D. W., & Holly, J. M. P. (2007) · Oncogene · doi:10.1038/sj.onc.1210397 · Cited by 145 · see citing works

Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells

Jin, Q., Yuan, L. X. H., Boulbés, D. R., Baek, J. M., Wang, Y., Gómez-Cabello, D., Hawke, D. H., Yeung, S. J., Lee, M. H., Hortobágyi, G. N., et al. (2010) · Breast Cancer Research · doi:10.1186/bcr2777 · Cited by 145 · see citing works

Targeted Therapy for Breast Cancer

Mohamed, A., Krajewski, K., Çakar, B., & Ma, C. X. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.07.005 · Cited by 139 · see citing works

Diabetes and altered carbohydrate metabolism in patients with cancer

Glicksman, A. S., & Rawson, R. W. (1956) · Cancer · doi:10.1002/1097-0142(195611/12)9:6 · Cited by 139 · see citing works

Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells

Guo, S., Liu, M., Wang, G., Torroella‐Kouri, M., & Gonzalez-Perez, R. R. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.01.002 · Cited by 137 · see citing works

Diabetes mellitus and prognosis in women with breast cancer

Zhao, X., & Ren, G.-S. (2016) · Medicine · doi:10.1097/md.0000000000005602 · Cited by 137 · see citing works

Endothelial Dysfunction in Diabetes Mellitus: Possible Involvement of Endoplasmic Reticulum Stress?

Basha, B. M., Samuel, S. M., Triggle, C. R., & Ding, H. (2012) · Experimental Diabetes Research · doi:10.1155/2012/481840 · Cited by 131 · see citing works

Adipocyte–Tumor Cell Metabolic Crosstalk in Breast Cancer

Hoy, A. J., Balaban, S., & Saunders, D. N. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.02.009 · Cited by 131 · see citing works

Metformin is synthetically lethal with glucose withdrawal in cancer cells

Menéndez, J. A., Oliveras‐Ferraros, C., Cufí, S., Corominas-Faja, B., Joven, J., Martı́n-Castillo, B., & Vázquez‐Martín, A. (2012) · Cell Cycle · doi:10.4161/cc.20948 · Cited by 129 · see citing works

ROS Links Glucose Metabolism to Breast Cancer Stem Cell and EMT Phenotype

Schieber, M., & Chandel, N. S. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.02.021 · Cited by 129 · see citing works

Fatty Acid Synthase (Fas) Predictive Strength in Poorly Differentiated Early Breast Carcinomas

Alò, P., Visca, P., Trombetta, G., Mangoni, A., Lenti, L., Monaco, S., Botti, C., Serpieri, D. E., & Tondo, U. D. (1999) · Tumori Journal · doi:10.1177/030089169908500108 · Cited by 129 · see citing works

6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase and tumor cell glycolysis

Chesney, J. A. (2006) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000241661.15514.fb · Cited by 128 · see citing works

Glucose Promotes Breast Cancer Aggression and Reduces Metformin Efficacy

Wahdan-Alaswad, R., Fan, Z., Edgerton, S. M., Liu, B., Deng, X.-S., Arnadottir, S. S., Richer, J. K., Anderson, S. M., & Thor, A. D. (2013) · Cell Cycle · doi:10.4161/cc.26641 · Cited by 125 · see citing works

Polyol Pathway Links Glucose Metabolism to the Aggressiveness of Cancer Cells

Schwab, A., Siddiqui, A., Vazakidou, M. E., Napoli, F., Böttcher, M., Menchicchi, B., Raza, U., Saatci, Ö., Krebs, A. M., Ferrazzi, F., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2834 · Cited by 124 · see citing works

Advanced glycation endproducts increase proliferation, migration and invasion of the breast cancer cell line MDA-MB-231

Sharaf, H., Matou‐Nasri, S., Wang, Q., Rabhan, Z., Al‐Eidi, H., Abdulrahman, A. A., & Ahmed, N. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.12.009 · Cited by 122 · see citing works

Chemical inhibition of acetyl-CoA carboxylase suppresses self-renewal growth of cancer stem cells

Corominas-Faja, B., Cuyàs, E., Gumuzio, J., Bosch‐Barrera, J., Leis, O., Martín, Á. G., & Menéndez, J. A. (2014) · Oncotarget · doi:10.18632/oncotarget.2059 · Cited by 119 · see citing works

The Association between Leptin Level and Breast Cancer: A Meta-Analysis

Niu, J., Jiang, L., Guo, W., Shao, L., Liu, Y., & Wang, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067349 · Cited by 117 · see citing works

Association of metformin with breast cancer incidence and mortality in patients with type II diabetes: A grade-assessed systematic review and meta-analysis

Tang, G. H., Satkunam, M., Pond, G. R., Steinberg, G. R., Blandino, G., Schünemann, H. J., & Muti, P. (2018) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0936 · Cited by 117 · see citing works

Obesity, Cholesterol Metabolism, and Breast Cancer Pathogenesis

McDonnell, D. P., Park, S. H., Goulet, M. T., Jasper, J. S., Wardell, S. E., Chang, C., Norris, J. D., Guyton, J. R., & Nelson, E. R. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1756 · Cited by 114 · see citing works

Hypercholesterolemia Induces Angiogenesis and Accelerates Growth of Breast Tumors In Vivo

Pelton, K., Coticchia, C. M., Curatolo, A. S., Schaffner, C. P., Zurakowski, D., Solomon, K. R., & Moses, M. A. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.03.006 · Cited by 109 · see citing works

The relationship between new-onset diabetes mellitus and pancreatic cancer risk: A case–control study

Ben, Q., Cai, Q.-C., Li, Z., Yuan, Y., Ning, X., Deng, S., & Wang, K. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.07.010 · Cited by 105 · see citing works

Glycemic memory associated epigenetic changes

Siebel, A. L., Fernández, A. Z., & El‐Osta, A. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.005 · Cited by 103 · see citing works

Skeletal Muscle Lipid Accumulation in Type 2 Diabetes May Involve the Liver X Receptor Pathway

Kase, E. T., Wensaas, A. J., Aas, V., Højlund, K., Levin, K., Thoresen, G. H., Beck‐Nielsen, H., Rustan, A. C., & Gaster, M. (2005) · Diabetes · doi:10.2337/diabetes.54.4.1108 · Cited by 102 · see citing works

DNA damage and breast cancer

Davis, J. D. (2011) · World Journal of Clinical Oncology · doi:10.5306/wjco.v2.i9.329 · Cited by 100 · see citing works

Cancer–testis antigen expression in triple-negative breast cancer

Curigliano, G., Viale, G., Ghioni, M., Jungbluth, A. A., Bagnardi, V., Spagnoli, G. C., Neville, A. M., Nolè, F., Rotmensz, N., & Goldhirsch, A. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq325 · Cited by 99 · see citing works

Metformin is not just an antihyperglycaemic drug but also has protective effects on the vascular endothelium

Triggle, C. R., & Ding, H. (2015) · Acta Physiologica · doi:10.1111/apha.12644 · Cited by 99 · see citing works

The Anti-Proliferative Effect of Metformin in Triple-Negative MDA-MB-231 Breast Cancer Cells Is Highly Dependent on Glucose Concentration: Implications for Cancer Therapy and Prevention

Zordoky, B. N. M., Bark, D., Soltys, C. L., Sung, M. M., & Dyck, J. R. B. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.01.023 · Cited by 98 · see citing works

17β-Estradiol Activates Glucose Uptake via GLUT4 Translocation and PI3K/Akt Signaling Pathway in MCF-7 Cells

Garrido, P., Morán, J., Alonso, A., Gonzalez, S. R., & González, C. (2013) · Endocrinology · doi:10.1210/en.2012-1558 · Cited by 93 · see citing works

Linking diabetes and cancer: a consensus on complexity

Renehan, A. G., Smith, U., & Kirkman, M. S. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60706-4 · Cited by 93 · see citing works

Carnitine palmitoyl transferase-1A (CPT1A): a new tumor specific target in human breast cancer

Pucci, S., Zonetti, M. J., Fisco, T., Polidoro, C., Bocchinfuso, G., Palleschi, A., Novelli, G., Spagnoli, L. G., & Mazzarelli, P. (2016) · Oncotarget · doi:10.18632/oncotarget.6964 · Cited by 93 · see citing works

Inhibition of the Hexosamine Biosynthetic Pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis

Ricciardiello, F., Votta, G., Palorini, R., Raccagni, I., Brunelli, L., Paiotta, A., Tinelli, F., D’Orazio, G., Valtorta, S., GIOIA, L. D., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0405-4 · Cited by 92 · see citing works

Lipid biology of breast cancer

Baumann, J., Sevinsky, C. J., & Conklin, D. S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.03.011 · Cited by 91 · see citing works

NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer

Ademuyiwa, F. O., Bshara, W., Attwood, K. M., Morrison, C., Edge, S. B., Ambrosone, C. B., O’Connor, T. L., Levine, E. G., Miliotto, A. J., Ritter, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038783 · Cited by 90 · see citing works

Targeting Aldose Reductase for the Treatment of Cancer

Tammali, R., Sk, S., & Ramana, K. V. (2011) · Current Cancer Drug Targets · doi:10.2174/156800911795655958 · Cited by 89 · see citing works

Rosiglitazone treatment increases plasma levels of adiponectin and decreases levels of resistin in overweight women with PCOS: a randomized placebo-controlled study

Majuri, A., Santaniemi, M., Rautio, K., Kunnari, A., Vartiainen, J., Ruokonen, A., Kesäniemi, Y. A., Tapanainen, J. S., Ukkola, O. H., & Morin-Papunen, L. C. (2007) · European Journal of Endocrinology · doi:10.1530/eje.1.02331 · Cited by 89 · see citing works

Type 2 Diabetes and Breast Cancer: The Interplay Between Impaired Glucose Metabolism and Oxidant Stress

Ferroni, P., Riondino, S., Buonomo, O., Palmirotta, R., Guadagni, F., & Roselli, M. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/183928 · Cited by 87 · see citing works

Systematic review and meta-analysis of insulin therapy and risk of cancer

Janghorbani, M., Dehghani, M., & Salehi-Marzijarani, M. (2012) · Hormones and Cancer · doi:10.1007/s12672-012-0112-z · Cited by 86 · see citing works

Autophagy in breast cancer and its implications for therapy.

Jain, K., Paranandi, K. S., Sridharan, S., & Basu, A. (2013) · PubMed Central · Cited by 84 · see citing works

Leptin, adipocytes and breast cancer: Focus on inflammation and anti-tumor immunity

Delort, L., Rossary, A., Farges, M., Vasson, M., & Caldefie‐Chezet, F. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.04.012 · Cited by 84 · see citing works

Plasma Leptin Levels and Risk of Breast Cancer in Premenopausal Women

Harris, H. R., Tworoger, S. S., Hankinson, S. E., ROSNER, B. A., & Michels, K. B. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0125 · Cited by 83 · see citing works

Cancer and diabetes: are we ready for prime time?

Smith, U., & Gale, E. A. M. (2010) · Diabetologia · doi:10.1007/s00125-010-1815-8 · Cited by 73 · see citing works

Contribution of individual PKC isoforms to breast cancer progression

Urtreger, A. J., Kazanietz, M. G., & Joffé, E. B. D. K. (2011) · IUBMB Life · doi:10.1002/iub.574 · Cited by 73 · see citing works

Highly specific role of the insulin receptor in breast cancer progression

Rostoker, R., Abelson, S., Bitton-Worms, K., Genkin, I., Ben-Shmuel, S., Dakwar, M., Orr, Z. S., Caspi, A., Tzukerman, M., & LeRoith, D. (2015) · Endocrine Related Cancer · doi:10.1530/erc-14-0490 · Cited by 72 · see citing works

Novel roles of the unfolded protein response in the control of tumor development and aggressiveness

Dejeans, N., Barroso, K., Fernández-Zapico, M. E., Afshin Samali, A., & Chevet, É. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.04.007 · Cited by 71 · see citing works

PKCθ promotes c-Rel–driven mammary tumorigenesis in mice and humans by repressing estrogen receptor α synthesis

Belguise, K., & Sonenshein, G. E. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32424 · Cited by 71 · see citing works

Effect of pioglitazone and rosiglitazone on mediators of endothelial dysfunction, markers of angiogenesis and inflammatory cytokines in type-2 diabetes

Vijay, S. K., Mishra, M., Kumar, H., & Tripathi, K. (2008) · Acta Diabetologica · doi:10.1007/s00592-008-0054-7 · Cited by 69 · see citing works

Diabetes and prognosis in a breast cancer cohort

Schrauder, M. G., Fasching, P. A., Häberle, L., Lux, M. P., Rauh, C., Hein, A., Bayer, C. M., Heusinger, K., Hartmann, A., Strehl, J. D., et al. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0960-2 · Cited by 67 · see citing works

Type 2 Diabetes and Obesity Metabolic Interactions: Common Factors for Breast Cancer Risk and Novel Approaches to Prevention and Therapy

Vona-Davis, L. C., & Rose, D. P. (2012) · Current Diabetes Reviews · doi:10.2174/157339912799424519 · Cited by 67 · see citing works

The Contribution of Cholesterol and its Metabolites to the Pathophysiology of Breast Cancer

Baek, A., & Nelson, E. R. (2016) · Hormones & cancer · doi:10.1007/s12672-016-0262-5 · Cited by 66 · see citing works

Recent Advances in the Use of Metformin: Can Treating Diabetes Prevent Breast Cancer?

Hatoum, D., & McGowan, E. M. (2015) · BioMed Research International · doi:10.1155/2015/548436 · Cited by 65 · see citing works

Effect of Different Doses of Metformin on Serum Testosterone and Insulin in Non-Diabetic Women With Breast Cancer: A Randomized Study

Campagnoli, C., Pasanisi, P., Abbà, C., Ambroggio, S., Biglia, N., Brucato, T., Colombero, R., Danese, S., Donadio, M., Venturelli, E., et al. (2012) · Clinical Breast Cancer · doi:10.1016/j.clbc.2012.03.004 · Cited by 65 · see citing works

Inhibition of apoptosis in human breast cancer cells: Role in tumor progression to the metastatic state

Fernández, Y., Gu, B., Martínez-Aranda, A., Torregrosa, A., & Sierra, À. (2002) · International Journal of Cancer · doi:10.1002/ijc.10628 · Cited by 64 · see citing works

Steady-State Pharmacokinetics of Metformin Is Independent of the OCT1 Genotype in Healthy Volunteers

Christensen, M. M. H., Højlund, K., Hother-Nielsen, O., Stage, T. B., Damkier, P., Beck-Nielsen, H., & Brøsen, K. (2015) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-015-1853-8 · Cited by 62 · see citing works

Metformin in breast cancer - an evolving mystery

Camacho, L., Dasgupta, A., & Jiralerspong, S. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0598-8 · Cited by 59 · see citing works

Metformin Decreases Circulating Androgen and Estrogen Levels in Nondiabetic Women With Breast Cancer

Campagnoli, C., Berrino, F., Venturelli, E., Abbà, C., Biglia, N., Brucato, T., Cogliati, P., Danese, S., Donadio, M., Zito, G., et al. (2013) · Clinical Breast Cancer · doi:10.1016/j.clbc.2013.08.012 · Cited by 59 · see citing works

Insulin receptor overexpression in 184B5 human mammary epithelial cells induces a ligand‐dependent transformed phenotype

Frittitta, L., Vigneri, R., Stampfer, M. R., & Goldfine, I. D. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240570411 · Cited by 56 · see citing works

Adiponectin and breast cancer

Chen, X., & Wang, Y. (2010) · Medical Oncology · doi:10.1007/s12032-010-9617-x · Cited by 54 · see citing works

Mitogenic effect of the insulin analogue glargine in malignant cells in comparison with insulin and IGF-I

Liefvendahl, E., & Arnqvist, H. (2008) · Hormone and Metabolic Research · doi:10.1055/s-2008-1062739 · Cited by 53 · see citing works

Cancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications

Balafoutas, D., Hausen, A. Z., Mayer, S., Hirschfeld, M., Jaeger, M., Denschlag, D., Gitsch, G., Jungbluth, A. A., & Stickeler, E. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-271 · Cited by 51 · see citing works

Cancer Risk in Type 2 Diabetes Mellitus: Metabolic Links and Therapeutic Considerations

Sun, G. E. C., & Kashyap, S. R. (2011) · Journal of Nutrition and Metabolism · doi:10.1155/2011/708183 · Cited by 51 · see citing works

Proliferation of human mammary cancer cells exposed to 27-hydroxycholesterol

Cruz, P., Torres, C. G., Ramirez, M. E., EPUÑÁN, M. J., Valladares, L., & Sierralta, W. D. (2010) · Experimental and Therapeutic Medicine · doi:10.3892/etm_00000084 · Cited by 51 · see citing works

Metformin Targets Glucose Metabolism in Triple Negative Breast Cancer

Wahdan-Alaswad, R. S., Edgerton, S. M., Salem, H. S., & Thor, A. D. (2018) · Journal of Oncology Translational Research · doi:10.4172/2476-2261.1000129 · Cited by 50 · see citing works

Roles of cancer/testis antigens (CTAs) in breast cancer

Li, Y., Li, J., Wang, Y., Zhang, Y., Chu, J., Sun, C., Fu, Z., Huang, Y., Zhang, H., Yuan, H., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.02.031 · Cited by 49 · see citing works

Redox Molecular Machines Involved in Tumor Progression

Parri, M., & Chiarugi, P. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.5040 · Cited by 47 · see citing works

27-Hydroxycholesterol: a potential endogenous regulator of estrogen receptor signaling

DuSell, C. D., & McDonnell, D. P. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.07.003 · Cited by 47 · see citing works

Neuregulin 1-HER axis as a key mediator of hyperglycemic memory effects in breast cancer

Park, J., Sarode, V. R., Euhus, D., Kittler, R., & Scherer, P. E. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214400109 · Cited by 44 · see citing works

Targeting Notch degradation system provides promise for breast cancer therapeutics

Liu, J., Shen, J., Wen, X.-F., Guo, Y., & Zhang, G. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.05.010 · Cited by 43 · see citing works

Could recombinant insulin compounds contribute to adenocarcinoma progression by stimulating local angiogenesis?

Rensing, K. L., Bloemendaal, F. M., Weijers, E. M., Richel, D. J., Buller, H. R., Koolwijk, P., van der Loos, C. M., Twickler, T. B., & von der Thüsen, J. H. (2010) · Diabetologia · doi:10.1007/s00125-010-1687-y · Cited by 40 · see citing works

How does the estrogen receptor work?

Gross, J. M., & Yee, D. (2002) · Breast Cancer Research · doi:10.1186/bcr424 · Cited by 40 · see citing works

A Novel Cancer Testis Antigen, A-Kinase Anchor Protein 4 (AKAP4) Is a Potential Biomarker for Breast Cancer

Saini, S., Jagadish, N., Gupta, A., Bhatnagar, A., & Suri, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057095 · Cited by 40 · see citing works

Lipid metabolism in human skeletal muscle cells: effects of palmitate and chronic hyperglycaemia

Aas, V., Rokling-Andersen, M. H., Wensaas, A. J., Thoresen, G. H., Kase, E. T., & Rustan, A. C. (2005) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.2004.01381.x · Cited by 39 · see citing works

Association between Metformin Use and Mortality after Cervical Cancer in Older Women with Diabetes

Han, K. C.-Z., Pintilie, M., Lipscombe, L. L., Lega, I. C., Milosevic, M., & Fyles, A. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-1008 · Cited by 37 · see citing works

Diabetes Mellitus and Carbohydrate Metabolism in Patients with Cancer

Glicksman, A. S., Myers, W. P. L., & Rawson, R. W. (1956) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)34572-2 · Cited by 37 · see citing works

Metformin Represses Glucose Starvation Induced Autophagic Response in Microvascular Endothelial Cells and Promotes Cell Death

Samuel, S. M., Ghosh, S., Majeed, Y., Arunachalam, G., Emara, M. M., Ding, H., & Triggle, C. R. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.03.001 · Cited by 37 · see citing works

Thiazolidinedione therapy and breast cancer risk in diabetic women: A systematic review and meta‐analysis

Du, R., Lin, L., Cheng, D., Xu, Y. H., Xu, M., Chen, Y., Wang, W., Bi, Y., Li, D., & Lu, J. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2961 · Cited by 35 · see citing works

The estrogen receptor as a mediator of the pathological actions of cholesterol in breast cancer

McDonnell, D. P., Chang, C.-Y., & Nelson, E. R. (2014) · Climacteric · doi:10.3109/13697137.2014.966949 · Cited by 33 · see citing works

The Warburg Phenomenon and Other Metabolic Alterations of Cancer Cells

Dakubo, G. D. (2010) · Springer eBooks · doi:10.1007/978-3-642-11416-8_2 · Cited by 32 · see citing works

Regulation of lipid metabolism in breast cancer provides diagnostic and therapeutic opportunities

Hilvo, M., & Orešiè, A. M. (2012) · Clinical Lipidology · doi:10.2217/clp.12.10 · Cited by 31 · see citing works

Analysis of AGE modified proteins and RAGE expression in HER2/neu negative invasive ductal carcinoma

Korwar, A. M., Bhonsle, H. S., Chougale, A. D., Kote, S., Gawai, K. R., Ghole, V. S., Koppikar, C. B., & Kulkarni, M. J. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.02.039 · Cited by 30 · see citing works

High expression of MAGE-A10 cancer-testis antigen in triple-negative breast cancer

Tanja, B. Č., Spagnoli, G. C., Juretić, A., Jakić‐Razumović, J., Podolski, P., & Šarić, N. (2011) · Medical Oncology · doi:10.1007/s12032-011-0120-9 · Cited by 29 · see citing works

Obesity, Diabetes, and Increased Cancer Progression

Kim, D.-S., & Scherer, P. E. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0077 · Cited by 312 · see citing works

A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan

Mohammed, I., Hollenberg, M. D., Ding, H., & Triggle, C. R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.718942 · Cited by 278 · see citing works

Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer

Varghese, E., Samuel, S. M., Líšková, A., Samec, M., Kubatka, P., & Büsselberg, D. (2020) · Cancers · doi:10.3390/cancers12082252 · Cited by 208 · see citing works

Hyperglycemia Associated Metabolic and Molecular Alterations in Cancer Risk, Progression, Treatment, and Mortality

Ramteke, P. L., Deb, A., Shepal, V., & Bhat, M. K. (2019) · Cancers · doi:10.3390/cancers11091402 · Cited by 156 · see citing works

Anti-Cancer Agents in Proliferation and Cell Death: The Calcium Connection

Varghese, E., Samuel, S. M., Sadiq, Z., Kubatka, P., Líšková, A., Beňačka, J., Pažinka, P., Kružliak, P., & Büsselberg, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20123017 · Cited by 129 · see citing works

The Role of Adipokines in Breast Cancer: Current Evidence and Perspectives

Christodoulatos, G. S., Spyrou, N., Kadillari, J., Psallida, S., & Dalamaga, Μ. (2019) · Current Obesity Reports · doi:10.1007/s13679-019-00364-y · Cited by 107 · see citing works

The obesity-breast cancer link: a multidisciplinary perspective

Devericks, E. N., Carson, M. S., McCullough, L. E., Coleman, M. F., & Hursting, S. D. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10043-5 · Cited by 109 · see citing works

Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer

Samuel, S., Varghese, E., Kubatka, P., Triggle, C., & Büsselberg, D. (2019) · Biomolecules · doi:10.3390/biom9120846 · Cited by 81 · see citing works

Hyperglycemia and Chemoresistance in Breast Cancer: From Cellular Mechanisms to Treatment Response

Qiu, J., Zheng, Q., & Meng, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.628359 · Cited by 69 · see citing works

High Glucose Represses the Anti-Proliferative and Pro-Apoptotic Effect of Metformin in Triple Negative Breast Cancer Cells

Varghese, S., Samuel, S. M., Varghese, E., Kubatka, P., & Büsselberg, D. (2019) · Biomolecules · doi:10.3390/biom9010016 · Cited by 58 · see citing works

Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells

Samuel, S. M., Varghese, E., Koklesová, L., Líšková, A., Kubatka, P., & Büsselberg, D. (2020) · Cancers · doi:10.3390/cancers12092482 · Cited by 53 · see citing works

Physical Exercise and the Hallmarks of Breast Cancer: A Narrative Review

García‐Chico, C., López‐Ortiz, S., Peñín‐Grandes, S., Pinto-Fraga, J., Valenzuela, P. L., Emanuele, E., Ceci, C., Graziani, G., Fiuza‐Luces, C., Lista, S., et al. (2023) · Cancers · doi:10.3390/cancers15010324 · Cited by 50 · see citing works

Glucagon-like peptide-1 receptor activation by liraglutide promotes breast cancer through NOX4/ROS/VEGF pathway

Liu, Z., Duan, X., Yuan, M., Yu, J. Y., Hu, X., Han, X., Lan, L., Liu, B., Wang, Y., & Qin, J. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120370 · Cited by 45 · see citing works

The emerging role of 27-hydroxycholesterol in cancer development and progression: An update

Jasim, S. A., Kzar, H. H., Hamad, M. H., Ahmad, I. S., Al-Gazally, M. E., Ziyadullaev, S., Sivaraman, R., Jawad, M. A., Hammid, A. T., Oudaha, K. H., et al. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109074 · Cited by 44 · see citing works

Clinical Significance of Elevated S100A8 Expression in Breast Cancer Patients

Wang, D., Liu, G., Wu, B., Chen, L., Zeng, L., & Pan, Y. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00496 · Cited by 42 · see citing works

Disrupting CISD2 function in cancer cells primarily impacts mitochondrial labile iron levels and triggers TXNIP expression

Karmi, O., Sohn, Y., Zandalinas, S. I., Rowland, L. M., King, S. D., Nechushtai, R., & Mittler, R. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.09.013 · Cited by 42 · see citing works

Impact of diabetes on outcomes in breast reconstruction: A systematic review and meta-analysis

Liu, Q., Aggarwal, A., Wu, M., Darwish, O. A., Baldino, K., Haug, V., Agha, R., Orgill, D. P., & Panayi, A. C. (2022) · Journal of Plastic Reconstructive & Aesthetic Surgery · doi:10.1016/j.bjps.2022.02.053 · Cited by 41 · see citing works

Diabetes and Cancer: Metabolic Association, Therapeutic Challenges, and the Role of Natural Products

Talib, W. H., Mahmod, A. I., Abuarab, S. F., Hasen, E., Munaim, A. A., Haif, S. K., Ayyash, A. M., Khater, S. H., Al-Yasari, I. H., & Kury, L. T. A. (2021) · Molecules · doi:10.3390/molecules26082179 · Cited by 36 · see citing works

Long non‑coding RNA nuclear paraspeckle assembly transcript 1 interacts with microRNA‑107 to modulate breast cancer growth and metastasis by targeting carnitine palmitoyltransferase‑1

Xiong, Y., Liu, Z., Li, Z., Wang, S., Shen, N., Yue, X., & Huang, T. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4869 · Cited by 36 · see citing works

Synthesis, α-glucosidase inhibition and antioxidant activity of the 7-carbo–substituted 5-bromo-3-methylindazoles

Mphahlele, M. J., Magwaza, N. M., Gildenhuys, S., & Setshedi, I. B. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103702 · Cited by 35 · see citing works

Action Mechanism of Metformin and Its Application in Hematological Malignancy Treatments: A Review

Zhang, Y., Zhou, F., Guan, J., Zhou, L., & Chen, B. (2023) · Biomolecules · doi:10.3390/biom13020250 · Cited by 34 · see citing works

Treatment With a Combination of Metformin and 2-Deoxyglucose Upregulates Thrombospondin-1 in Microvascular Endothelial Cells: Implications in Anti-Angiogenic Cancer Therapy

Mathews Samuel, S., Satheesh, N. J., Ghosh, S., Büsselberg, D., Majeed, Y., Ding, H., & Triggle, C. R. (2019) · Cancers · doi:10.3390/cancers11111737 · Cited by 28 · see citing works

Pleiotropic effects of anti-diabetic drugs: A comprehensive review

Nath, M., Bhattacharjee, K., & Choudhury, Y. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173349 · Cited by 27 · see citing works

In-Silico Study of Immune System Associated Genes in Case of Type-2 Diabetes With Insulin Action and Resistance, and/or Obesity

Eldakhakhny, B. M., Sadoun, H. A., Choudhry, H., & Mobashir, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.641888 · Cited by 23 · see citing works

A Systematic Review: Does Insulin Resistance Affect the Risk and Survival Outcome of Breast Cancer in Women?

Srinivasan, M., Arzoun, H., Lekshmana Bharathi, G. K., & Thangaraj, S. R. (2022) · Cureus · doi:10.7759/cureus.21712 · Cited by 22 · see citing works

Tirzepatide—Friend or Foe in Diabetic Cancer Patients?

Samuel, S. M., Varghese, E., Kubatka, P., & Büsselberg, D. (2022) · Biomolecules · doi:10.3390/biom12111580 · Cited by 22 · see citing works

Cross Talk between COVID-19 and Breast Cancer

Parmar, H. S., Nayak, A., Gavel, P. K., Jha, H. C., Bhagwat, S., & Sharma, R. (2021) · Current Cancer Drug Targets · doi:10.2174/1568009621666210216102236 · Cited by 21 · see citing works

Hyperglycemia induces an immunosuppressive microenvironment in colorectal cancer liver metastases by recruiting peripheral blood monocytes through the CCL3-CCR1 axis

Peng, H., Pan, Y., Sun, Y., Wang, X., Fan, X., Wang, Y., Zhao, L., Li, X., Yan, D., Chen, J., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-011310 · Cited by 20 · see citing works

A selenium-containing selective histone deacetylase 6 inhibitor for targeted in vivo breast tumor imaging and therapy

Tang, C. C., Du, Y., Liang, Q. Y., Cheng, Z., & Tian, J. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb00383e · Cited by 20 · see citing works

The impacts of dipeptidyl- peptidase 4 (DPP-4) inhibitors on common female malignancies: A systematic review

Niazmand, A., Nedaeinia, R., Vatandoost, N., Jafarpour, S., Safabakhsh, S., Kolahdouz, M., Ferns, G. A., & Salehi, R. (2024) · Gene · doi:10.1016/j.gene.2024.148659 · Cited by 19 · see citing works

Antipsychotic agent pimozide promotes reversible proliferative suppression by inducing cellular quiescence in liver cancer

Chen, J., Zhang, L., Cai, N., Zhang, Z., & Ji, K. (2019) · Oncology Reports · doi:10.3892/or.2019.7229 · Cited by 19 · see citing works

Metformin and Malignant Tumors: Not Over the Hill

Leng, W., Jiang, J., Chen, B., & Wu, Q. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s326378 · Cited by 18 · see citing works

A Molecular Link Between Diabetes and Breast Cancer: Therapeutic Potential of Repurposing Incretin-based Therapies for Breast Cancer

Jaiswal, P., Tripathi, V., Nayak, A., Kataria, S., Lukashevich, V., Das, A. K., & Parmar, H. S. (2021) · Current Cancer Drug Targets · doi:10.2174/1568009621666210901101851 · Cited by 18 · see citing works

The assessment of breast cancer biomarkers in diagnosis, prognosis and treatment monitoring: integrated analysis

Królewska‐Daszczyńska, P., Englisz, A., Morawiec, M.-L., Miśkiewicz, J., Gołębski, M., & Mielczarek‐Palacz, A. (2025) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-025-06271-1 · Cited by 17 · see citing works

The crosstalk within the breast tumor microenvironment in type II diabetes: Implications for cancer disparities

Ennis, C. S., Llévenes, P., Qiu, Y., Dries, R., & Denis, G. V. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1044670 · Cited by 17 · see citing works

New benzimidazole‐oxadiazole derivatives: Synthesis, α‐glucosidase, α‐amylase activity, and molecular modeling studies as potential antidiabetic agents

Çevik, U. A., Çeli̇k, İ., Paşayeva, L., Fatullayev, H., Bostancı, H. E., Özkay, Y., & Kaplancıklı, Z. A. (2023) · Archiv der Pharmazie · doi:10.1002/ardp.202200663 · Cited by 17 · see citing works

Synthesis, α-amylase and α-glucosidase inhibition and molecular docking studies of indazole derivatives

Nawaz, M., Taha, M., Qureshi, F., Ullah, N., Selvaraj, M., Shahzad, S., Chigurupati, S., Abubshait, S. A., Ahmad, T., Chinnam, S., et al. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1947892 · Cited by 17 · see citing works

Automated knowledge-assisted mitosis cells detection framework in breast histopathology images

Tan, X. J., Mustafa, N., Mashor, ‪. Y., & Rahman, K. S. A. (2021) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2022081 · Cited by 16 · see citing works

Systemic Diseases and Gastrointestinal Cancer Risk

Malkani, N., & Rashid, M. U. (2023) · Journal of Cancer & Allied Specialties · doi:10.37029/jcas.v9i2.473 · Cited by 15 · see citing works

Management of metabolic adverse events of targeted therapies and immune checkpoint inhibitors in cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper

Silvestris, N., Argentiero, A., Beretta, G. D., Bartolo, P. D., Montagnani, M., Danesi, R., Ferrari, P., D’Oronzo, S., Gori, S., Russo, A. D., et al. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103066 · Cited by 16 · see citing works

Endocrine‐disrupting compounds and metabolomic reprogramming in breast cancer

Winz, C., Zong, W., & Suh, N. (2023) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23506 · Cited by 14 · see citing works

RelB sustains endocrine resistant malignancy: an insight of noncanonical NF-κB pathway into breast Cancer progression

Wang, M., Zhang, Y., Xu, Z., Qian, P., Sun, W., Wang, X., Zhang, J., Xia, T., Xu, Y., & Tang, J. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00613-x · Cited by 14 · see citing works

Prognostic and clinicopathological significance of fatty acid synthase in breast cancer: A systematic review and meta-analysis

Liu, B., Qi, P., Wang, Y., Qiu, J., Zhu, J., & Ma, R. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1153076 · Cited by 14 · see citing works

Hormone receptor status influences the impact of body mass index and hyperglycemia on the risk of tumor relapse in early-stage HER2-positive breast cancer patients

Ligorio, F., Zambelli, L., Bottiglieri, A., Castagnoli, L., Zattarin, E., Lobefaro, R., Ottini, A., Vingiani, A., Pupa, S. M., Bianchi, G., et al. (2021) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359211006960 · Cited by 14 · see citing works

Body mass index and type 2 diabetes and breast cancer survival: a Mendelian randomization study.

Liu, Y.-S., Wu, P., Chou, W., Vikram, R., Chen, W.-T., Yang, S.-L., Bolla, M. K., Wang, Q., Dennis, J., Chan, T. L., et al. (2021) · PubMed Central · doi:10.17863/cam.73616 · Cited by 14 · see citing works

Complexity of insulin resistance in early-onset colorectal cancer

Samuel, S. M., Varghese, E., & Büsselberg, D. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.03.033 · Cited by 13 · see citing works

The association between cancer-related fatigue and diabetes from pre-chemotherapy to 6 months post-chemotherapy

Kleckner, A. S., Kleckner, I. R., Culakova, E., Shayne, M., Belcher, E. K., Gudina, A. T., Williams, A. M., Onitilo, A. A., Hopkins, J. O., Gross, H. M., et al. (2022) · Supportive Care in Cancer · doi:10.1007/s00520-022-07189-x · Cited by 13 · see citing works

Hyperglycemia and O-GlcNAc transferase activity drive a cancer stem cell pathway in triple-negative breast cancer

Ayodeji, S. A., Bao, B., Teslow, E. A., Polin, L., Dyson, G. E., Bollig-Fischer, A. B., & Fehl, C. (2023) · Cancer Cell International · doi:10.1186/s12935-023-02942-6 · Cited by 13 · see citing works

Downregulation of tRF-Cys-GCA-029 by hyperglycemia promotes tumorigenesis and glycolysis of diabetic breast cancer through upregulating PRKCG translation

Huang, Y., Chen, C., Liu, Y., Tan, B., Qin, X., Chen, Q., Wang, Y., Yang, W., He, J., Zhou, D., et al. (2024) · Breast Cancer Research · doi:10.1186/s13058-024-01870-1 · Cited by 13 · see citing works

Advancements in the study of glucose metabolism in relation to tumor progression and treatment

Zhao, M., Chen, Y., & Yang, L. (2024) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2024.08.001 · Cited by 13 · see citing works

Analyzing the symptoms in colorectal and breast cancer patients with or without type 2 diabetes using EHR data

Luo, X., Storey, S., Gandhi, P., Zhang, Z., Metzger, M., & Huang, K. (2021) · Health Informatics Journal · doi:10.1177/14604582211000785 · Cited by 14 · see citing works

The impact of cadmium exposure on breast cancer risk: Exploring dose-response relationships and mediating effects

Lu, Y., Dang, Y., Chen, Y., Chen, Y., Xu, H., Li, X., Fan, X., Yang, J., Ling, X., Ma, L., et al. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.118247 · Cited by 12 · see citing works

Metformin, the Rise of a New Medical Therapy for Endometriosis? A Systematic Review of the Literature

Stochino-Loi, E., Major, A. L., Gillon, T. E. R., Ayoubi, J.-M., Féki, A., & de Jolinière, J. B. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.581311 · Cited by 12 · see citing works

The pro-proliferative effect of interferon-γ in breast cancer cell lines is dependent on stimulation of ASCT2-mediated glutamine cellular uptake

Silva, C., Andrade, N., Rodrigues, I., Ferreira, A. C., Soares, M. L., & Martel, F. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120054 · Cited by 12 · see citing works

Metformin-Based Combination Approaches for Triple-Negative Breast Cancer

Sirhan, Z., Nada, A. A., Anabtawi, N., Thyagarajan‐Sahu, A., & Sahu, R. P. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17050558 · Cited by 11 · see citing works

Lactoferrin Inhibits the Development of T2D-Induced Colon Tumors by Regulating the NT5DC3/PI3K/AKT/mTOR Signaling Pathway

Li, H., Yao, Q., Li, C., Fan, L., Wu, H., Zheng, N., & Wang, J. (2022) · Foods · doi:10.3390/foods11243956 · Cited by 11 · see citing works

Metabolic heterogeneity in TNBCs: A potential determinant of therapeutic efficacy of 2-deoxyglucose and metformin combinatory therapy

Samuel, S. M., Varghese, E., Satheesh, N. J., Triggle, C. R., & Büsselberg, D. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114911 · Cited by 11 · see citing works

The effects of physical exercise therapy on weight control: its regulation of adipocyte physiology and metabolic capacity

Park, H.-J., Rhie, S. J., & Shim, I. (2023) · Journal of Exercise Rehabilitation · doi:10.12965/jer.2346232.116 · Cited by 11 · see citing works

Hyperglycemia Promotes Liver Metastasis of Colorectal Cancer via Upregulation of Integrin αvβ6

Wang, B., Wang, S., Wang, W., Liu, E., Guo, S., Zhao, C., Niu, J., & Zhang, Z. (2021) · Medical Science Monitor · doi:10.12659/msm.930921 · Cited by 11 · see citing works

A novel quantitative measurement method for irregular tubules in breast carcinoma

Tan, X. J., Mustafa, N., Mashor, ‪. Y., & Rahman, K. S. A. (2021) · Engineering Science and Technology an International Journal · doi:10.1016/j.jestch.2021.08.008 · Cited by 11 · see citing works

Diabetes, metformin and breast cancer: a tangled web

Lohmann, A. E., & Goodwin, P. J. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2020.12.014 · Cited by 11 · see citing works

Cancer in Ecuadorian subjects with Laron syndrome (ELS)

Guevara‐Aguirre, J., Peña, G., Pazmiño, G., Acosta, W., Saavedra, J., Lescano, D., Guevara, A., & Gavilanes, A. W. D. (2023) · Endocrine Related Cancer · doi:10.1530/erc-22-0389 · Cited by 10 · see citing works

Influence of Type 2 Diabetes and Adipose Tissue Dysfunction on Breast Cancer and Potential Benefits from Nutraceuticals Inducible in Microalgae

Sergi, D., Melloni, M., Passaro, A., & Neri, L. M. (2024) · Nutrients · doi:10.3390/nu16193243 · Cited by 9 · see citing works

Association between consumption of sweeteners and endometrial cancer risk: a systematic review and meta-analysis of observational studies

Li, H., Zhang, Y., He, Y., Huang, J., Yao, J., & Zhuang, X. (2023) · British Journal Of Nutrition · doi:10.1017/s0007114523001484 · Cited by 8 · see citing works

Exploring the 3,5-Dibromo-4,6-dimethoxychalcones and Their Flavone Derivatives as Dual α-Glucosidase and α-Amylase Inhibitors with Antioxidant and Anticancer Potential

Nkoana, J. K., Mphahlele, M. J., More, G. K., & Choong, Y. S. (2024) · Antioxidants · doi:10.3390/antiox13101255 · Cited by 8 · see citing works

Triglyceride-glucose index and triglyceride-glucose–body mass index as prognostic factors for early stage breast cancer patients receiving neoadjuvant chemotherapy

Li, F., Gao, T., Li, Z., Dou, H., Ba, Y., Jia, S., Luo, D., & Xiao, M. (2025) · Translational Oncology · doi:10.1016/j.tranon.2025.102292 · Cited by 8 · see citing works

In Vitro α-Glucosidase and α-Amylase Inhibition, Cytotoxicity and Free Radical Scavenging Profiling of the 6-Halogeno and Mixed 6,8-Dihalogenated 2-Aryl-4-methyl-1,2-dihydroquinazoline 3-Oxides

Magwaza, N. M., More, G. K., Gildenhuys, S., & Mphahlele, M. J. (2023) · Antioxidants · doi:10.3390/antiox12111971 · Cited by 8 · see citing works

Dulaglutide as a Demethylating Agent to Improve the Outcome of Breast Cancer

Tatsch, J. M., Furman, D. P., Nobre, R. M., Wurzer, K. M., da Silva, L. C., Picheth, G. F., Ramos, E. A., Acco, A., & Klassen, G. (2023) · Epigenomics · doi:10.2217/epi-2023-0332 · Cited by 8 · see citing works

Circular RNA CLASP1 modulates the GLI1/SNAIL axis and enhances macrophage polarization in breast cancer

Zhou, L.-J., Liu, M., Liu, F., Wang, Z., Li, X., Peng, X., Ma, W., Guo, P., Yuan, L., Wołczyński, S., et al. (2025) · Oncogene · doi:10.1038/s41388-025-03627-2 · Cited by 9 · see citing works

New evidence: Metformin unsuitable as routine adjuvant for breast cancer: a drug-target mendelian randomization analysis

Xu, J., Zhu, Q.-L., Bi, Y.-M., & Peng, Y. (2024) · BMC Cancer · doi:10.1186/s12885-024-12453-w · Cited by 7 · see citing works

Metformin and malignant neoplasms: a possible mechanism of antitumor action and prospects for use in practice

Олегович, К. К., Safina, Е. R., Gaimakova, D. V., Frolova, Y. S., Oganesyan, I. Y., Sadertdinova, A. G., Александровна, Н. К., Islamgulov, A. K., Karimova, A. R., Galimova, A. M., et al. (2022) · Problems of Endocrinology · doi:10.14341/probl13097 · Cited by 7 · see citing works

Impact of type 2 diabetes on malignancies of the female reproductive system

Espinoza, C., Veas-Torres, J., Miranda, D. I., & Owen, G. I. (2026) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2026.101459 · Cited by 6 · see citing works

Metformin as an activator of AMP-activated protein kinase. Known and new mechanisms of action

Mkrtumyan, A. M., Маркова, Т. Н., Ovchinnikova, M. A., Ivanova, I. A., & Kuzmenko, K. V. (2023) · Diabetes Mellitus · doi:10.14341/dm13044 · Cited by 6 · see citing works

Non-vesicular nanocarriers for breast cancer management: current advances, challenges, and future perspective

Kumari, N. U., Pardhi, E. R., Madan, J., Singh, P. K., & Mehra, N. K. (2024) · International Journal of Polymeric Materials · doi:10.1080/00914037.2024.2338135 · Cited by 6 · see citing works

Hierarchical F-actin microstructures and multi-passage viscoelasticity evolution in living cancer cells under varying glucose environment

Li, Z., Li, Z., Yao, S., Jiang, H., Zhang, X., Zheng, Y. L., & Zhu, W. (2024) · Acta Mechanica Sinica · doi:10.1007/s10409-024-24243-x · Cited by 6 · see citing works

Synthesis and profiling (in vitro and in silico) of the 6-methoxy/hydroxy substituted 7-acetyl-2-aryl-5-bromobenzofurans for antihyperglycemic, cytotoxic and antioxidant properties

Ajiboye, A. T., Nkoana, J. K., More, G. K., Elhenawy, A. A., & Mphahlele, M. J. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108465 · Cited by 5 · see citing works

Triglyceride-Glucose Index: A Candidate Prognostic Marker in HR-Positive/HER2-Negative Metastatic Breast Cancer Patients Treated With CDK4/6 Inhibitors

Önder, T., Ateş, Ö., Öner, İ., & Karaçin, C. (2024) · Clinical Breast Cancer · doi:10.1016/j.clbc.2024.05.004 · Cited by 5 · see citing works

The pro‐proliferative effect of insulin in human breast epithelial DMBA ‐transformed and non‐transformed cell lines is PI3K ‐, mTOR ‐ and GLUT1 ‐dependent

Silva, C., Andrade, N., Guimarães, J. T., Cardoso, E., Meireles, C., Pinto, V., Paiva, J. S., & Martel, F. (2022) · Cell Biochemistry and Function · doi:10.1002/cbf.3681 · Cited by 5 · see citing works

The Effect of Different Glucose Concentrations on the Antiproliferative Activity of Metformin in MCF-7 Breast Cancer Cells

Nurzhan, S., Bekezhankyzy, Z., Ding, H., Berdigaliyev, N., Sergazy, S. D., Gulyayev, A., Shulgau, Z., Triggle, C. R., & Aljofan, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15092186 · Cited by 5 · see citing works

Therapeutic Potential of Methylindoline Derivative in Ameliorating Cadmium‐Induced Nephritis Experimented in Zebrafish Model

Nayak, S. P. R. R., Herold, A., Shiny, M., Vedula, G. S., Soundharrajan, I., Almutairi, B. O., Namasivayam, S. K. R., Kumaradoss, K. M., & Arockiaraj, J. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70312 · Cited by 5 · see citing works

tRNA Fragments in Diabetes Mellitus

Zhang, J., Liu, M., & Li, Z. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120405 · Cited by 4 · see citing works

LINC01140 Hinders the Development of Breast Cancer Through Targeting miR-200b-3p to Downregulate DMD

Peng, G., Yan, J., Shi, P., & Li, H. (2023) · Cell Transplantation · doi:10.1177/09636897231211202 · Cited by 4 · see citing works

Segmentation of Relevant Region in Breast Histopathology Images using FCM with Guided Initialization

Jian, T. X., Mustafa, N., Yusoff, M. M., & Shakir, A. R. K. (2019) · Journal of Physics Conference Series · doi:10.1088/1742-6596/1372/1/012028 · Cited by 4 · see citing works

Glycemic load impacts the response of acquired resistance in breast cancer cells to chemotherapeutic drugs in vitro

Adham, S. A., Kalbani, A. Y. S. A., Al‐Zeheimi, N., Dalali, M. A., Kharusi, N. A., Siddiqi, A., & Maskari, A. A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0311345 · Cited by 3 · see citing works

Exploring the active ingredients of Banzhilian and its mechanism of action on diabetic Gastric cancer based on network pharmacology

Cao, H., Song, H., Zhou, W., Lv, X., Liu, X., Xiang, Z., Fu, R., Cheng, Y., Chen, J., Wang, S., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-98214-6 · Cited by 3 · see citing works

Correlations of Diabetes and the Risk Factors with the Survival of Breast Cancer Patients

Nasab, M. S., Yazdimoghaddam, H., Mohaddes, S. T., & Rakhshani, M. H. (2022) · Iranian Journal of Breast Disease · doi:10.30699/ijbd.14.4.31 · Cited by 3 · see citing works

Glucose-dependent effect of insulin receptor isoforms on tamoxifen antitumor activity in estrogen receptor-positive breast cancer cells

Stella, S., Massimino, M., Manzella, L., Parrinello, N. L., Vitale, S. R., Martorana, F., & Vigneri, P. G. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1081831 · Cited by 3 · see citing works

Recurrence Pattern in the Presence of Hepatosteatosis in Breast Cancer: Does It Facilitate Liver Metastasis?

Kuş, T., Çınkır, H. Y., Aktaş, G., & Abalı, H. (2020) · Future Oncology · doi:10.2217/fon-2019-0634 · Cited by 2 · see citing works

Deciphering odontogenic myxoma: the role of copy number variations as diagnostic signatures

Zhang, A., Zhang, J., Li, X., Zhou, X., Feng, Y., Zhu, L., Zhang, H., Sun, L., & Li, T. (2024) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2400081 · Cited by 2 · see citing works

Multi-omics insights into biomarkers of breast cancer associated diabetes: a computational approach

Loganathan, T., & Doss, C. G. P. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1572500 · Cited by 2 · see citing works

Economic burden of diabetes among medicare beneficiaries with cancer

McDaniel, C. C., Loh, F. E., Rockwell, D. M., McDonald, C. P., & Chou, C. (2021) · Journal of Pharmaceutical Health Services Research · doi:10.1093/jphsr/rmab002 · Cited by 2 · see citing works

Association between serum lipid and papillary thyroid cancer: a retrospective study in China

Zhang, Z., Lan, X., You, L., Han, D., Tang, H., Zhao, Y. H., & Hu, X. (2025) · PeerJ · doi:10.7717/peerj.19644 · Cited by 2 · see citing works

Repurposing of Anti-diabetic Drug in Cancer Prevention

Bhattacharjee, A. (2020) · Novel Approaches in Cancer Study · doi:10.31031/nacs.2020.04.000598 · Cited by 2 · see citing works

Is breast cancer a civilization disease? Common components of type 2 diabetes and breast cancer

WIJAS, K., SZALA-CZERWONKA, K., Rejmer, A., WOŚ, N., ROJEK, K., BEDNARZ, L., Bialic, K., Bakalarczyk, R., BIALIC, A., & Majewski, P. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.24.01.008 · Cited by 2 · see citing works

Prevalence and influence of overweight and obesity on clinical and epidemiological profile of breast cancer patients in the North of Mato Grosso, Brazil: a retrospective cross-sectional study

Ferreira, K. A. D. S., Fé, V. V. D. M., de Lima, V. P. B., Dias, F. A., Medeiros, T. C., de Queiroz, D. A., Rossini, A., da Silveira, É. F., Alegranci, P., & de Queiroz, E. A. I. F. (2023) · Scientific Electronic Archives · doi:10.36560/16620231733 · Cited by 2 · see citing works

Effect and safety of combined Gegen Qinlian decoction/metformin in the treatment of diabetes mellitus in patients, and its influence on serum C peptide and glycosylated hemoglobin

Chen, J., Xu, Y., Zhao, Y., Liu, G., Cui, J., Li, Y., & Li, W. (2022) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v21i5.20 · Cited by 2 · see citing works

[Scandinavian Dental Journal 1893-1967].

Löfgren, Å. B. (1967) · PubMed · Cited by 2 · see citing works

ASSOCIAÇÃO ENTRE DIABETES MELLITUS, OBESIDADE E O RISCO DE RECORRÊNCIA E MORTALIDADE DO CÂNCER

Sinezio, P. R. A. D. O., Costa, K. F. D. L., de Carvalho, F. P. B., da Silva, F. G., Delfino, V. D. F. R., & Queiroz, T. A. (2024) · Enfermagem em Foco · doi:10.21675/2357-707x.2024.v15.e-2024101 · Cited by 1 · see citing works

Diabetes Mellitus and Carbohydrate Metabolism in Patients with Cancer

Glicksman, A. S., Myers, W. P. L., & Rawson, R. W. (1956) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)34572-2 · Cited by 37 · see citing works

Diabetes, metformin and breast cancer: a tangled web

Lohmann, A. E., & Goodwin, P. J. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2020.12.014 · Cited by 11 · see citing works

Antidiabetic Drugs in Breast Cancer Patients

Garczorz, W., Kosowska, A., & Francuz, T. (2024) · Cancers · doi:10.3390/cancers16020299 · Cited by 21 · see citing works

Type 2 Diabetes and Obesity Metabolic Interactions: Common Factors for Breast Cancer Risk and Novel Approaches to Prevention and Therapy

Vona-Davis, L. C., & Rose, D. P. (2012) · Current Diabetes Reviews · doi:10.2174/157339912799424519 · Cited by 67 · see citing works

Research Progress of Correlation between Breast Cancer and Type 2 Diabetes

Xiao-fe, T. (2014) · Medical Recapitulate